Compounds, compositions and methods are provided for modulating the
expression of PTP1B. The compositions comprise antisense compounds,
particularly antisense oligonucleotides, targeted to nucleic acids
encoding PTP1B. Methods of using these compounds for modulation of PTP1B
expression and for treatment of diseases associated with expression of
PTP1B are provided.